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 Background : Somatotropic effects are described in the skin. Indeed, 
acromegaly is in part clinically recognized by cutaneous coarsening. The actual 
changes in tensile properties associated with the cutaneous manifestations are 
largely unknown. Objectives : To study the relationships between the skin tensile 
properties and the severity of acromegaly as assessed by serum levels of growth 
hormone  (GH) and insulin-like growth factor-1 (IGF-1). Patients and method : 
Assessments were made in 13 patients with acromegaly treated by somatostatin 
agonists combined or not with surgery. A total of 39 age-and sex-matched healthy 
subjects served as controls. Skin tensile properties were measured on the forearm 
and nape of the neck using a computerized suction device. Results : Significant 
differences were yielded between the skin tensile properties in patients and normal 
subjects. The highest IGF-1 values in the patientsʼ medical records were positively 
correlated with both skin distensibility and biologic elasticity. The most recent IGF-1 
serum levels were negatively correlated with the visco-elastic ratio. No correlations 
were yielded between any of the biomechanical parameters and GH levels, disease 
duration and treatment dosages, respectively. Conclusion : Skin in acromegaly 
appears to be functionally more redundant and elastic than normal skin. The 
biomechanical changes appear quite different from those observed in other diseases 
with collagen deposition such as diabetes mellitus and scleroderma. 
Key Words : Acromegaly. Dermis. Mechanical properties. Growth hormone. Insulin-
like growth factor-1. 
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  The overall tensile properties of skin largely depend on the composition and 
architecture of the dermis [1]. As a consequence, many connective tissue disorders 
are in part characterized by typical changes in the tensile characteristics of the skin 
[1-3]. Several non-invasive methods are available to assess such features [4]. 
 In acromegaly, skin is enlarged, acquires a doughy texture and typically 
presents disproportionate skinfolds [5, 6]. Skin coarsening is primarily due to an 
increase in the amount of collagen and glycosaminoglycans [7-9]. Objectivation of the 
functional consequences of this organomegaly has not yet been studied thoroughly. 
Reports have shown that injections of growth hormone (GH) in adults may result in 
increased skin thickness [10] and in unusual viscoelastic changes in the skin [11]. In 
fact, there is ample evidence that fibroblasts and other cells of the skin respond to 
GH and insulin-like growth factor 1 (IGF-1) [12-22]. These findings suggest that 
epidermal, adnexal and dermal cell populations can be direct and indirect tarrgets for 
GH [22]. Indeed, transgenic mice overexpressing GH show skin overgrowth with 
increased dermal thickness, significant dermal fibrosis and replacement of 
subcutaneous adipose tissue by fibrous tissue [23]. By contrast, GH and IGF-1 
deficiencies show effects on the skin by decreasing its thickness and weakening its 
mechanical properties [24, 25]. 
 The aim of the present study was to assess the in vivo tensile properties of the 
skin in patients treated for acromegaly, and to compare it with serum levels of GH 
and IGF-1. 
Patients and methods 
 Thirteen patients with acromegaly were enrolled in the study (Table I). The 
M:F sex ratio was 1.6. All but one patients were treated with lanreotide (Somatuline®, 
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Ipsen) or octreotide (Table I). Serum levels of GH (GH IRMA C.T., BC 1012, Biocode, 
Belgium) and IGF-1 (IGF-1 IRMA, BC 1010, Biocode, Belgium) were retrieved from 
the medical files. The highest GH and IGF-1 values in the medical records of each 
patient were considered to be representative of the climax severity of the disease. 
The serum levels of these biomolecules recorded at the time of the study were also 
retained to assess the current status of the disease. A control group was formed by 
39 age- and sex-matched healthy subjects (3 normal matched volunteers for each 
patient with acromegaly). 
 The tensile properties of the skin were evaluated using a computerized suction 
device (Cutometer® SEM 474, C + K Electronic, Cologne, Germany) equipped with a 
hand-held probe having a central suction head of 4 mm in diameter. The time/strain 
mode was used with three cycles of 5-s traction under negative pressure of 500 mbar 
separated by 5-s relaxation periods (Fig. 1). The skin tensile parameters considered 
in this study have been previously described in detail [4, 26-30]. Each load cycle of 
suction to the skin results in an immediate elastic distension (ED), recorded at 0.15 s, 
followed by a delayed visoelastic distension, ending with the measurement of the 
maximum distension (MD) of the skin obtained after a 5-s traction. When the traction 
is discontinued, the skin tends to return to its initial position. During that phase, two 
parameters are recorded, namely the immediate elastic retraction (ER) after 0.1 s of 
relaxation and the resilient distension (RD) after a 5-s relaxation time. These 
measures were taken during the first and third load cycles. The differential distension 
(DD) was measured as the difference in MD between the third and the first cycles. In 
addition,, certain biologically relevant ratios of these parameters were calculated 
(Table II). 
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 Measurements were taken from the left mid volar forearm and the nape of the 
neck. The values were expressed as means (M) and SD with calculation of the 
coefficient of variation (CV =102 SD. M -1). Differences between body sites were 
tested for their statistical significance using the paired Student t-test. Regression 
analysis models were applied to evaluate the relationships between the 
biomechanical values and hormonal levels. The best model, i.e. linear, logarithmic, 
exponential or power, was chosen on the basis of the highest coefficient of 
correlation (r). A p value lower than 0.05 was considered significant. 
 Results 
 For each biomechanical parameter, interindividual variability was quite large 
among patients with acromegaly (Table III). In contrast, intraindividual differences 
between the two body test sites were very low. In absence of any significant regional 
differences (Table III), the values obtained from the volar forearm and the nape of the 
neck were averaged for further search of correlations with hormonal values. 
Compared to matched normal subjects, patients with acromegaly showed a 
significant increase in MD (p < 0.01) combined with significant reductions in VER (p < 
0.05), EF (p < 0.01) and RER (p < 0.05). 
 From all the correlations tested between each of the GH and IGF-1 levels, 
disease duration, somatostatin agonist dosages and skin tensile parameters, only 
three reached significance (Fig. 2a, b, 3). MD and BE increased in parallel with the 
values of maximum IGF-1 (linear correlation, r = 0.60 and 0.64, respectively, p < 
0.01) . In contrast, VER values were negatively correlated with the most recent IGF-1 
serum levels (logarithmic correlation, r = -0.54, p < 0.05). 
 Discussion 
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 There is ample evidence that skin is under the influence of many 
neuroendocrine influences [22]. Previous studies indicated that the precise 
assessments of the mechanical properties of this organ reveal quite specific changes 
in hormone-related connective tissue disorders including menopause, diabetes and 
GH deficiency [1, 11, 25, 28-33]. In addition, such assessments reveal some 
correlations between the severity in skin and bone alterations [30]. Thus, determining 
the mechanical properties of skin may also represent a non-invasive tool for 
predicting internal manifestations of some connective tissue disorders. 
 It is recognized that the suction method parameters do not lend 
themselves to quick simple explanation. In the present test design, the 4-mm probe 
aperture allowed the suction force to be transmitted to the first 1 to 1.5 mm of the 
dermis. This limitation permits indeed a comparison between the intrinsic properties 
of normal skin and those of a presumably thicker dermis in acromegaly. Hence, the 
well recognized effect of tissue thickness upon the biomechanical properties of skin 
[1, 25, 34] is minimized. Our study indicates that the skin tensile properties  are 
markedly altered in patients treated for acromegaly. This was indeed not a surprise 
because there is ample clinical clue for such changes. In the overall assessment, 
skin in acromegaly exhibited increased distensibility with more subtle changes in its 
viscoelastic aspects. The interindividual variations in skin tensile properties were 
larger in the patients than in the healthy subjects. 
 The present data distinguish the most recent and the maximum GH and IGF-1 
imbalances in acromegaly. No significant correlation was yielded between GH serum 
levels and the skin tensile properties. In contrast, distinct correlations were found 
between each of the IGF-1 levels and values of some biomechanical parameters. 
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This may be explained by the quite stable intra-individual IGF-1 values in contrast 
with the variable amplitude and frequency in GH pulses [12, 35]. There was evidence 
that both maximum skin distensibility (MD) and biologic elasticity (BE) increased with 
the disease severity as assessed by the highest recorded IGF-1 values. Such a 
finding is at variance with other skin conditions including diabetes and scleroderma 
which are also associated with deposits of collagen [27-29]. In these disorders, MD is 
typically decreased and elasticity changes are variable. Indeed, the functional 
consequences of increased collagen content in the dermis may be quite different 
according to the agencement of the fibrils and bundles. It is noteworthy that such 
structures are stretched and tightly bound each other in scleroderma, resulting in 
increased skin stiffness. Skin in acromegaly shows a different microanatomy and 
lacks these tensile characteristics. It appears to be more enlarged, redundant and 
doughy rather than tight and stretched. Hormonal changes in acromegaly induce 
imbalanced soft tissue enlargement with increased dermal thickness [12]. This 
feature cannot explain the MD increase, but rather would be suspected to be 
responsible for the reverse. The present data suggest that the skin envelope is more 
increased in area than in thickness. Thus, skin increases in size at a greater extent 
than needed to simply cover the volume of the underlying bones, muscles and 
subcutaneous tissues. 
 The short term effects of hormonal disturbance in acromegaly appear different 
from those related to the climax severity of the disease. Viscosity of skin (VER) 
decreased proportionally to the increase in the last IGF-1 recorded value. Such a 
negative correlation was relatively weak and the scatterplot showed considerable 
spread. In addition, this aspect is at variance with previous findings made in GH 
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abusers among adult body builders [11]. In this latter group of individuals, the 
musculature was indeed impressive and much more developed than in patients with 
acromegaly. Hence, the skin tension imposed by the volume of muscles was likely 
different in this distinct group of individuals. In addition, fluid retention was likely 
present in the dermis. A direct effect of somatostatin agonists on the tensile 
properties of skin cannot be dismissed from the present observations. However, no 
correlation was found in this study between the biochemical parameters and the 
mean drug dosages and the total amount of lanreotide and octreotide administered to 
the patients. 
 In conclusion, IGF-1 levels appear to control, at least in part, the tensile 
properties of skin. The excess in IGF-1 may yield distinct short-term and long-term 
functional consequences on the skin physiology. The predictive value of the presently 
described biomechanical alterations for the severity of internal manifestations 
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 Table I -  Demographic data of the patients with acromegaly 
 
Patient Gender Age 
(year) 
Time elapsed since 
diagnosis (year) 
Surgery Somatostatin agonist 
treatment 
Duration (years) 




1 M 54 17 + none healed 
2 M 65 5 0 Lanreotide 5 y, 90 mg statilization 
3 M 65 1 + Lanreotide 0.5 y, 0 mg healed 
4 M 38 1 + Lanreotide 0.5 y, 0 mg healed 
5 M 34 5 + Lanreotide 3 y, 120 mg moderate improvement 
6 M 49 11 + Lanreotide 11 y, 120 mg stabilization 
7 M 73 5 0 Lanreotide 5 y, 90 mg stabilization 
8 M 51 13 + Octreotide 11 y, 60 mg stabilization 
9 F 71 5 0 Lanreotide 5 y, 120 mg stabilization 
10 F 43 17 + Lanreotide 3 y, 120 mg stabilization 
11 F 67 13 + Lanreotide 13 y, 60 mg stabilization 
12 F 56 9 + Lanreotide 4 y, 90 mg stabilization 
13 F 31 6 0 Lanreotide 6 y, 120 mg Stabilization 
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Table II Rheologic ratios (%) quantifying the skin tensile strength 
  
 
Extension phase during skin elevation 
          Viscoelastic ratio, VER = 102 (MD-ED)ED-1 
Recovery phase during skin relaxation 
          Biologic elasticity, BE = 102 (Md-RD)MD-1 
          Relative elastic recovery, RER = 102 (MD-ER)MD-1 
          Elastic function, EF = 102  (MD-ER) ED-1 
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 Table III : Mean ± SD and coefficient of variation (CV, %) of the 
biomechanical parameters evaluated on the volar forearm and neck 
 
 
 Acromegaly Controls 
Parameter    Volar forearm_ Neck Volar forearm 
MD (nm) 257 ± 76 (29.6 %) 255 ± 96 (37.6 %)_ 161±33 (20.5 %) 
BE (%) 70 ± 12 (17.1 %)_ 71 ± 14 (19.7 %) 73±8 (18 %) 
VER  (%) 47 ± 21 (44.7 %) 48 ± 18 (37.5 %) 97±10 (10,3 %) 
EF  (%) 57 ± 21 (36.8 %) 52 ± 22 (42.3 %) 70±15 (21,4 %) 
RER  (%) 39 ± 11 (28.2 %) 35 ± 12 (34.3 %) 56±8 (14,3 %) 
DD  (nm) 24 ± 21 (87.5 %) 23 ± 13 (56.5 %) 31±8 (25,8 %) 
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 Figure captions 
 
Fig 1 Deformation of skin in response to three cycles 5s- suction separated by 5-s 
relaxation. See text for the definition of the biomechanical parameters. 
 
Fig 2 Scatterplot of (a) MD values µm and (b) BE values (%) according to the 
maximum IGF-1 levels (ng/ml) in the patientsʼ history. Positive linear 
relationships are yielded (MD : r = 0.60, p < 0.01; BE : r = 0.64, p < 0.01). 
 
Fig 3  Scatterplot of VER values (%) according to the most recent IGF-1 levels 
(ng/ml) in the patientʼs history. A negative linear relationship is yielded (r = -
0.50, p < 0.05). 
 
